Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tomorrow Biostasis

Explore full profile

Advancing biostasis by providing high-quality cryopreservation services in the heart of Europe

Berlin, GermanyFounded 2020Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Tomorrow Biostasis and the history behind them.

About Tomorrow Biostasis

Tomorrow Bio is a Berlin-based biotechnology company specializing in human cryopreservation, also known as biostasis. The company provides emergency medical stabilization and long-term preservation of the human body at ultra-low temperatures (-196°C) immediately after legal death. The aim is to preserve biological functions and prevent cellular decay, allowing for the possibility of future revival when medical advancements enable the treatment of currently incurable conditions. Tomorrow Bio also manages educational content and public engagement around life extension and cryonics, seeking to normalize biostasis as a legitimate medical option. In collaboration with European Biostasis Foundation (EBF), the company offers standby, stabilization, and transport services, and stores preserved bodies in dedicated cryogenic facilities in Switzerland. Its services are primarily available via subscription-based plans that include long-term storage, standby readiness, and other support infrastructure. Tomorrow Bio serves individuals interested in extending life and future medical possibilities, positioning itself at the intersection of medicine, technology, and long-term thinking.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Berlin, Germany
Sector
Health Tech & Medtech

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Blast. Club
  • TruVenturo GmbH
  • Nils Regge

Series A2 investors entered at this stage

  • TEC Ventures
  • Asia Venture Group
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇩🇪 Germany52.2%
🇫🇷 France21.7%
🇨🇭 Switzerland13%
🇱🇹 Lithuania4.3%
🇺🇸 United States4.3%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tomorrow Biostasis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tomorrow Biostasis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.